Agreement with Accelera
Glucox Biotech has signed an agreement with Accelera Srl, Milano, Italy. Accelera will evaluate pharmacokinetics and time course of brain uptake of Glucox’ lead compounds in mice.
Two of Glucox’ NOX4 small molecule inhibitors have been shown to protect brain from nerve cell damage in a situation of induced acute ischemic stroke. To further elucidate the positive action of these compounds, time course of brain uptake will be investigated and evaluated.
lista escape room
You really make it appear really easy along with your presentation but
I find this matter to be actually something which I feel I’d by no means understand.
It seems too complicated and extremely huge for me. I am looking ahead for your subsequent publish, I’ll attempt to get the
cling of it! Escape rooms hub
CathrynI
I was looking through some of your blog posts on this internet site and I believe this internet site
is real informative! Continue posting..